Concepedia

Publication | Open Access

Bivalent Vaccine Effectiveness Against Type-Specific HPV Positivity: Evidence for Cross-Protection Against Oncogenic Types Among Dutch STI Clinic Visitors

DOIFull Paper Access

84

Citations

32

References

2017

Year

Petra J. Woestenberg, Audrey J. King, Birgit van Benthem, Robine Donken, Suzan Leussink, Fiona van der Klis, Hester E. de Melker, Marianne A. B. van der Sande, Christian J. P. A. Hoebe, Johannes A. Bogaards,
The Journal of Infectious Diseases

Abstract

We demonstrated high VE of the bivalent vaccine against HPV-16/18 and cross-protection against HPV-45/35/31/52. Protection against HPV-16/18 was sustained up to 6 years postvaccination.

References

YearCitations

Page 1